These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 18379470

  • 1. [Depakine in the therapy of epilepsy in children and adolescents].
    Guzeva VI, Fomina MIu, Korostovtsev DD, Guzeva VV, Guzeva OV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):34-9. PubMed ID: 18379470
    [Abstract] [Full Text] [Related]

  • 2. [Depakene (sodium valproate) in the treatment of epilepsy in children and adolescents: efficiency and safety].
    Petrukhin AS, Mukhin KIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(6):20-7. PubMed ID: 11517881
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Pylaeva OA, Petrukhin AS, Voronkova KV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):61-5. PubMed ID: 15554145
    [Abstract] [Full Text] [Related]

  • 4. [The use of depakene and depakene-chrono in idiopathic generalized epilepsy].
    Perunova NIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(9):45-7. PubMed ID: 14571673
    [Abstract] [Full Text] [Related]

  • 5. [Convulex and its place in epilepsy treatment with original valproates].
    Gromov SA, Kim KV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):18-21. PubMed ID: 12378876
    [Abstract] [Full Text] [Related]

  • 6. [Depakine syrup in the treatment of therapy-resistant epilepsy].
    Maksumova EL, Muzychenko AP, Sokolova LV, Zheleznova EV.
    Ter Arkh; 1996; 68(10):72-4. PubMed ID: 9026952
    [Abstract] [Full Text] [Related]

  • 7. [The use of valproates-generics in the treatment of epileptic patients].
    Gromov SA, Tabulina SD.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):22-6. PubMed ID: 15875940
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of epileptic seizures resistant to phenobarbital in children during the first year of life].
    Rudenko AIu, Konoplianko TV, Stetsiuk RA.
    Lik Sprava; 2002; (1):52-6. PubMed ID: 11944381
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic failure, treatment and non-treatment of childhood epilepsy].
    Garaizar C, Pérez-García J, Gil-Antón J, Prats JM.
    Rev Neurol; 1998 Sep; 27(157):467-72. PubMed ID: 9774821
    [Abstract] [Full Text] [Related]

  • 10. [Clinical importance of EEG changes during the treatment of epilepsy with valproate (depakene chrono)].
    Zenkov LR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002 Sep; 102(3):20-6. PubMed ID: 11957341
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [Abstract] [Full Text] [Related]

  • 12. [Depakin 300 and Depakin-chrono in the therapy of epilepsy].
    Karlov VA, Vlasov PN, Khabibova AO.
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999 Mar; 99(10):20-5. PubMed ID: 10536807
    [Abstract] [Full Text] [Related]

  • 13. The investigation of EEG specificity in epileptic children during Depakine therapy.
    Khachidze I, Gugushvili M, Makashvili M, Maloletnev V.
    Int J Neurosci; 2016 Oct; 126(10):912-21. PubMed ID: 26290045
    [Abstract] [Full Text] [Related]

  • 14. [The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy].
    Sołowiej E, Sobaniec W.
    Neurol Neurochir Pol; 2003 Oct; 37(5):991-1003. PubMed ID: 15174247
    [Abstract] [Full Text] [Related]

  • 15. Risk of excessive weight gain in epileptic children treated with valproate.
    Novak GP, Maytal J, Alshansky A, Eviatar L, Sy-Kho R, Siddique Q.
    J Child Neurol; 1999 Aug; 14(8):490-5. PubMed ID: 10456757
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of the specific prolonged form of valproic acid (in the form of granules) in children with different forms of epilepsy].
    Milovanova OA, Stepanishchev IL, Pykov MI, Pobuta OV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Aug; 112(6 Pt 2):32-6. PubMed ID: 22983236
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie).
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [Abstract] [Full Text] [Related]

  • 18. [A retrospective study comparing two formulations of valproic acid].
    Gutiérrez-Gutiérrez G, Poza-Aldea JJ, Tellería-Elmezábal J, Martí-Massó JF.
    Rev Neurol; 2001 Dec; 42(3):129-32. PubMed ID: 16475132
    [Abstract] [Full Text] [Related]

  • 19. [Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy].
    Czapiński P, Terczyński A.
    Neurol Neurochir Pol; 1996 Dec; 30(3):419-26. PubMed ID: 8965976
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of efficacy of convulex-retard in epilepsy treatment].
    Gromov SA, Korovina SA, Eroshina ES.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006 Dec; 106(5):35-7. PubMed ID: 16768223
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.